Literature DB >> 9284698

Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men.

A G Johansson1, E F Eriksen, E Lindh, B Langdahl, W F Blum, A Lindahl, O Ljunggren, S Ljunghall.   

Abstract

Idiopathic osteoporosis in younger individuals could be related to reduced bone formation rather than increased bone resorption, and disturbances in GH or insulin-like growth factor (IGF)-I production could be involved in its pathogenesis. In the present study, men with idiopathic osteoporosis were compared with healthy men, with respect to bone histomorphometry and to serum levels of IGF-I, IGF-II, IGF binding protein (IGFBP)-2 and IGFBP-3, and 24-h urinary excretion of GH. Mean wall thickness was reduced in the patients (48.3 +/- 7.2 vs. 61.7 +/- 5.4 microns, P < 0.001). Also, resorption depth was decreased, albeit to a lesser degree (54.4 +/- 3.8 vs. 60.7 +/- 5.3 microns, P < 0.01), thus creating a pronounced negative balance (-6.04 +/- 9.8 vs. 0.96 +/- 3.2 microns, P < 0.05). In the patients, serum concentrations of IGFBP-3 were reduced, compared with controls, with a 46% lower mean value; whereas levels of IGF-I, IGF-II, IGFBP-2, and GH were similar in the two groups. Thus, there was a significant negative balance caused by a pronounced decrease in wall thickness in men with idiopathic osteoporosis. The finding of low IGFBP-3 levels in these patients is interesting, in view of previous clinical and experimental findings, but its pathophysiological significance remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9284698     DOI: 10.1210/jcem.82.9.4148

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; David W Dempster; Robert R Recker; Emily M Stein; Joan M Lappe; Hua Zhou; Andreas J Wirth; G Harry van Lenthe; Thomas Kohler; Alexander Zwahlen; Ralph Müller; Clifford J Rosen; Serge Cremers; Thomas L Nickolas; Donald J McMahon; Halley Rogers; Ronald B Staron; Jeanette LeMaster; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

2.  Premenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.

Authors:  A Cohen; R R Recker; J Lappe; D W Dempster; S Cremers; D J McMahon; E M Stein; J Fleischer; C J Rosen; H Rogers; R B Staron; J Lemaster; E Shane
Journal:  Osteoporos Int       Date:  2011-03-02       Impact factor: 4.507

Review 3.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

Review 4.  Idiopathic osteoporosis in men.

Authors:  Luigi Gennari; John P Bilezikian
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

5.  Teriparatide for idiopathic osteoporosis in premenopausal women: a pilot study.

Authors:  Adi Cohen; Emily M Stein; Robert R Recker; Joan M Lappe; David W Dempster; Hua Zhou; Serge Cremers; Donald J McMahon; Thomas L Nickolas; Ralph Müller; Alexander Zwahlen; Polly Young; Julie Stubby; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2013-03-29       Impact factor: 5.958

6.  Muscle mass deficits are associated with bone mineral density in men with idiopathic vertebral fracture.

Authors:  J H Macdonald; S F Evans; M W J Davie; C A Sharp
Journal:  Osteoporos Int       Date:  2006-11-11       Impact factor: 4.507

Review 7.  Unresolved issues in osteoporosis in men.

Authors:  E Seeman
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

8.  GH-binding protein is related to bone mineral density in non-obese androgenized women.

Authors:  M Legan; J Osredkar; S Fisker; A Kocijancic
Journal:  J Endocrinol Invest       Date:  2006-02       Impact factor: 4.256

9.  Quantifying the Balance Between Total Bone Formation and Total Bone Resorption: An Index of Net Bone Formation.

Authors:  Albert Shieh; Weijuan Han; Shinya Ishii; Gail A Greendale; Carolyn J Crandall; Arun S Karlamangla
Journal:  J Clin Endocrinol Metab       Date:  2016-06-23       Impact factor: 5.958

10.  Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss.

Authors:  Sunil J Wimalawansa; Julia P Grimes; Alan C Wilson; Donald R Hoover
Journal:  J Clin Endocrinol Metab       Date:  2009-06-23       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.